Publication | Closed Access

Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease

InflammationChronic Inflammatory DiseasesImmunologyGastroenterologyChronic InflammationScheduled Maintenance TreatmentInflammatory MarkerTrough Serum InfliximabMedicineInflammatory DiseaseClinical Outcome